One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Treatment Issues Related to the Use of Psychedelics, Trichotillomania, Social Anxiety Disorder, Schizophrenia, and Opioid Use Disorder
Ned H. Kalin, M.D.
doi : 10.1176/appi.ajp.20230209
Volume 180, Issue 5
Cautious Optimism for a New Treatment Option for Body-Focused Repetitive Behavior Disorders
Erica L. Greenberg, M.D., and Daniel A. Geller, M.D.
The Attention Bias Modification Approach to Anxiety: Origins, Limitations, and Opportunities
Colin MacLeod, M.Phil., D.Phil.
Treating Pathologies of the Will
Sophia Vinogradov, M.D., and Piper Meyer-Kalos, Ph.D.
An Argument for Antipsychotic Polypharmacy
Robert W. Buchanan, M.D., and Julie Kreyenbuhl, Pharm.D., Ph.D.
Drug Overdose Prevention: An Exercise in Optimism
Hilary S. Connery, M.D., Ph.D., and Roger D. Weiss, M.D.
Psychedelics as Transformative Therapeutics
Bryan L. Roth, M.D., Ph.D., and Ryan H. Gumpper, Ph.D.
Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder
Jon E. Grant, M.D., M.P.H., Eve Chesivoir, B.A., Stephanie Valle, B.A., Dustin Ehsan, M.D., Samuel R Chamberlain, M.B.B.Chir., Ph.D.
Attention Bias Modification Treatment Versus a Selective Serotonin Reuptake Inhibitor Or Waiting List Control for Social Anxiety Disorder: A Randomized Clinical Trial
Gal Arad, M.A., Omer Azriel, M.A., Daniel S. Pine, M.D., Amit Lazarov, Ph.D., Omer Sol, M.D., Mark Weiser, M.D., Eddie Garber, M.D., Miki Bloch, M.D., Yair Bar-Haim, Ph.D.
A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT
L. Felice Reddy, Ph.D., Shirley M. Glynn, Ph.D., Jessica E. McGovern, Ph.D., Catherine A. Sugar, Ph.D., Eric A. Reavis, Ph.D., Michael F. Green, Ph.D.
Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia
Heidi Taipale, Ph.D., Antti Tanskanen, Ph.D., Jari Tiihonen, M.D., Ph.D.
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder
Laura Brandt, Ph.D., Mei-Chen Hu, Ph.D., Ying Liu, Ph.D., Felipe Castillo, M.D., Gabriel J. Odom, Ph.D., Raymond R. Balise, Ph.D., Daniel J. Feaster, Ph.D., Edward V. Nunes, M.D., Sean X. Luo, M.D., Ph.D.
Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects
Joshua D. Rosenblat, M.D., Marisa Leon-Carlyle, M.D., Shaun Ali, M.S.W., R.S.W., M. Ishrat Husain, M.R.C.Psych., Roger S. McIntyre, M.D.
